 |
Vicebio
Last updated: October 14, 2024
CEO - Emmanuel Hanon
UK | Funding: $100M (+)
Website: https://vicebio.com/
Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.
Website: https://vicebio.com/
Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.
